FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2156605908> ?p ?o ?g. }

• W2156605908 endingPage "906" @default.
• W2156605908 startingPage "894" @default.
• W2156605908 abstract "Pericytes are key regulators of vascular maturation, but their value for cardiac repair remains unknown.We investigated the therapeutic activity and mechanistic targets of saphenous vein-derived pericyte progenitor cells (SVPs) in a mouse myocardial infarction (MI) model.SVPs have a low immunogenic profile and are resistant to hypoxia/starvation (H/S). Transplantation of SVPs into the peri-infarct zone of immunodeficient CD1/Foxn-1(nu/nu) or immunocompetent CD1 mice attenuated left ventricular dilatation and improved ejection fraction compared to vehicle. Moreover, SVPs reduced myocardial scar, cardiomyocyte apoptosis and interstitial fibrosis, improved myocardial blood flow and neovascularization, and attenuated vascular permeability. SVPs secrete vascular endothelial growth factor A, angiopoietin-1, and chemokines and induce an endogenous angiocrine response by the host, through recruitment of vascular endothelial growth factor B expressing monocytes. The association of donor- and recipient-derived stimuli activates the proangiogenic and prosurvival Akt/eNOS/Bcl-2 signaling pathway. Moreover, microRNA-132 (miR-132) was constitutively expressed and secreted by SVPs and remarkably upregulated, together with its transcriptional activator cyclic AMP response element-binding protein, on stimulation by H/S or vascular endothelial growth factor B. We next investigated if SVP-secreted miR-132 acts as a paracrine activator of cardiac healing. In vitro studies showed that SVP conditioned medium stimulates endothelial tube formation and reduces myofibroblast differentiation, through inhibition of Ras-GTPase activating protein and methyl-CpG-binding protein 2, which are validated miR-132 targets. Furthermore, miR-132 inhibition by antimiR-132 decreased SVP capacity to improve contractility, reparative angiogenesis, and interstitial fibrosis in infarcted hearts.SVP transplantation produces long-term improvement of cardiac function through a novel paracrine mechanism involving the secretion of miR-132 and inhibition of its target genes." @default.
• W2156605908 created "2016-06-24" @default.
• W2156605908 creator A5011359646 @default.
• W2156605908 creator A5012598859 @default.
• W2156605908 creator A5014777117 @default.
• W2156605908 creator A5033029478 @default.
• W2156605908 creator A5041297561 @default.
• W2156605908 creator A5042591594 @default.
• W2156605908 creator A5045720585 @default.
• W2156605908 creator A5047015948 @default.
• W2156605908 creator A5052263643 @default.
• W2156605908 creator A5054764500 @default.
• W2156605908 creator A5066613178 @default.
• W2156605908 creator A5071326768 @default.
• W2156605908 creator A5072601716 @default.
• W2156605908 date "2011-09-30" @default.
• W2156605908 modified "2023-10-17" @default.
• W2156605908 title "Transplantation of Human Pericyte Progenitor Cells Improves the Repair of Infarcted Heart Through Activation of an Angiogenic Program Involving Micro-RNA-132" @default.
• W2156605908 cites W1965903389 @default.
• W2156605908 cites W1966786218 @default.
• W2156605908 cites W1969530887 @default.
• W2156605908 cites W1978238305 @default.
• W2156605908 cites W1983517713 @default.
• W2156605908 cites W1994248886 @default.
• W2156605908 cites W2004013719 @default.
• W2156605908 cites W2009036920 @default.
• W2156605908 cites W2009404031 @default.
• W2156605908 cites W2013243629 @default.
• W2156605908 cites W2016669156 @default.
• W2156605908 cites W2019123554 @default.
• W2156605908 cites W2022632639 @default.
• W2156605908 cites W2023538608 @default.
• W2156605908 cites W2025838486 @default.
• W2156605908 cites W2050974735 @default.
• W2156605908 cites W2055469901 @default.
• W2156605908 cites W2067591094 @default.
• W2156605908 cites W2068707753 @default.
• W2156605908 cites W2096349247 @default.
• W2156605908 cites W2096433394 @default.
• W2156605908 cites W2096671156 @default.
• W2156605908 cites W2107247243 @default.
• W2156605908 cites W2110054944 @default.
• W2156605908 cites W2114140981 @default.
• W2156605908 cites W2116763826 @default.
• W2156605908 cites W2116795951 @default.
• W2156605908 cites W2119583980 @default.
• W2156605908 cites W2128340149 @default.
• W2156605908 cites W2128408920 @default.
• W2156605908 cites W2129944973 @default.
• W2156605908 cites W2141097507 @default.
• W2156605908 cites W2145280222 @default.
• W2156605908 cites W2148943967 @default.
• W2156605908 cites W2152255329 @default.
• W2156605908 cites W2152771603 @default.
• W2156605908 cites W2155160938 @default.
• W2156605908 cites W2168438265 @default.
• W2156605908 cites W2169211736 @default.
• W2156605908 doi "https://doi.org/10.1161/circresaha.111.251546" @default.
• W2156605908 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3623091" @default.
• W2156605908 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21868695" @default.
• W2156605908 hasPublicationYear "2011" @default.
• W2156605908 type Work @default.
• W2156605908 sameAs 2156605908 @default.
• W2156605908 citedByCount "308" @default.
• W2156605908 countsByYear W21566059082012 @default.
• W2156605908 countsByYear W21566059082013 @default.
• W2156605908 countsByYear W21566059082014 @default.
• W2156605908 countsByYear W21566059082015 @default.
• W2156605908 countsByYear W21566059082016 @default.
• W2156605908 countsByYear W21566059082017 @default.
• W2156605908 countsByYear W21566059082018 @default.
• W2156605908 countsByYear W21566059082019 @default.
• W2156605908 countsByYear W21566059082020 @default.
• W2156605908 countsByYear W21566059082021 @default.
• W2156605908 countsByYear W21566059082022 @default.
• W2156605908 countsByYear W21566059082023 @default.
• W2156605908 crossrefType "journal-article" @default.
• W2156605908 hasAuthorship W2156605908A5011359646 @default.
• W2156605908 hasAuthorship W2156605908A5012598859 @default.
• W2156605908 hasAuthorship W2156605908A5014777117 @default.
• W2156605908 hasAuthorship W2156605908A5033029478 @default.
• W2156605908 hasAuthorship W2156605908A5041297561 @default.
• W2156605908 hasAuthorship W2156605908A5042591594 @default.
• W2156605908 hasAuthorship W2156605908A5045720585 @default.
• W2156605908 hasAuthorship W2156605908A5047015948 @default.
• W2156605908 hasAuthorship W2156605908A5052263643 @default.
• W2156605908 hasAuthorship W2156605908A5054764500 @default.
• W2156605908 hasAuthorship W2156605908A5066613178 @default.
• W2156605908 hasAuthorship W2156605908A5071326768 @default.
• W2156605908 hasAuthorship W2156605908A5072601716 @default.
• W2156605908 hasBestOaLocation W21566059081 @default.
• W2156605908 hasConcept C113045295 @default.
• W2156605908 hasConcept C123012128 @default.
• W2156605908 hasConcept C126322002 @default.
• W2156605908 hasConcept C134018914 @default.
• W2156605908 hasConcept C146285616 @default.
• W2156605908 hasConcept C15215337 @default.
• W2156605908 hasConcept C167734588 @default.

• next